2022 recap: Dr. Chi highlights milestones in stone disease

SAP Partner | <b>UCSF Health</b>

“We've got a lot of movement in terms of understanding how stones form, some pharmaceutical interventions that we can use to prevent stones, and then how we can get even less invasive to try to get stones in the least morbid way for our patients,” says Thomas Chi, MD.

Urology Times® is wrapping up the year by diving into some milestones from different urologic specialties. In this interview, Thomas Chi, MD, recaps some of the clinical and research highlights in stone disease from the past year. Chi is a professor and associate chair at the University of California, San Francisco.